Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125188) titled 'Exploratory Clinical Study of Intratumoral EC001 Oncolytic Adenovirus Injection in Patients with Advanced Solid Tumors' on May 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences
Condition:
Solid tumor
Intervention:
High-dose group:High-dose EC001 injection group
Medium-dose group:Medium-dose EC001 injection group
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-06-01
Target Sample Size: High-dose group:3;Medium-dose group:3;Low-dose group:3;
Countries of Recruitment:
China
To know more, visit ...